AC
EGRX

Aristides Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Aristides Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,451
Closed -$86K – 380
2023
Q4 		$86K Buy
+16,451
New +$86K 0.03% 236